Modified EASIX scores predict severe CRS/ICANS in patients with acute myeloid leukemia following CLL1 CAR-T cell therapyYifan Zhao, Mingfeng Zhao, Yu Zhang et al.|Annals of Hematology|2024Cited by 32
Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantationWenyi Lu, Mingfeng Zhao, Hairong Lyu et al.|Leukemia|2024Cited by 11
Prophylactic or Preemptive Donor-Derived CD19 CAR-T Cell Infusion for Preventing Relapse in High-Risk B-ALL after Allogeneic Hematopoietic Stem Cell TransplantationWenyi Lu, Mingfeng Zhao, Meng Zhang et al.|Blood|2023Cited by 1
Prophylactic or Preemptive Infusion Of Donor-Derived CD19 CAR-T Cell Therapy in High-Risk B-Cell Acute Lymphoblastic Leukaemia Following Allogeneic Transplantation: A Post-Hoc Analysis of Two Clinical TrialsWenyi Lu, Mingfeng Zhao, Meng Zhang et al.|SSRN Electronic Journal|2023Cited by 0